A Clinical Comparison of Slow- and Rapid-Escalation Treprostinil Dosing Regimens in Patients with Pulmonary Hypertension

Author： Skoro-Sajer Nika  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.47, Iss.9, 2008-01, pp. : 611-618

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A rapid-escalation treprostinil regimen is at least as effective and well tolerated as a slow-escalation regimen

By  

Inpharma, Vol. 1, Iss. 1656, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

The Role of Treprostinil in the Management of Pulmonary Hypertension

By Skoro-Sajer Nika   Lang Irene  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 4, 2008-01 ,pp. : 213-217

Adis International

Access to resources Recommend Favorite

Treprostinil therapy for pulmonary artery hypertension

By Horn Evelyn M   Barst Robyn J  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1615-1622

Informa Healthcare

Access to resources Recommend Favorite

Continuous SC treprostinil sodium effective in pulmonary hypertension

By  

Inpharma, Vol. 1, Iss. 1332, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Inhaled treprostinil is an effective, well-tolerated add-on therapy for patients with pulmonary arterial hypertension (PAH) treated with bosentan

By  

Inpharma, Vol. 1, Iss. 1561, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite